Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibodies
antibodies
Sanofi Commits Potential $6B to IGM (Antibodies) in New Collab
BioSpace
Tue, 03/29/22 - 10:53 am
Sanofi
IGM Biosciences
oncology
immunology
antibodies
drug discovery
cancer
Synthetic Antibodies to be Designed with Organoids
Science & Enterprise
Tue, 03/22/22 - 11:13 pm
antibodies
synthetic antibodies
organoids
Prellis Biologics
Sanofi
Novartis backs Epsilogen's bid to turn 'Cinderella antibody' into new class of cancer drug
Fierce Biotech
Wed, 03/2/22 - 12:10 pm
Novartis
antibodies
funding
cancer
Epsiologen
FDA bans use of Lilly, Regeneron COVID drugs due to Omicron
Pharmaforum
Tue, 01/25/22 - 10:44 am
COVID-19
Eli Lilly
Regeneron
antibodies
Omicron COVID-19 variant
GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand
Fierce Pharma
Sat, 01/22/22 - 02:14 pm
GSK
Vir Biotechnology
COVID-19
antibodies
drug manufacturing
Samsung BioLogics
Prellis, Bristol Myers Squibb collaborate to discover antibodies
Pharmaceutical Business Review
Fri, 01/14/22 - 10:58 am
Prellis Biologics
Bristol Myers Squibb
antibodies
drug discovery
AstraZeneca's COVID therapy becomes first antibody approved for immunocompromised people preexposure
Fierce Pharma
Wed, 12/8/21 - 11:35 pm
AstraZeneca
COVID-19
antibodies
FDA
Emergency Use Authorization
New data shows GSK-Vir drug works against all Omicron mutations
Reuters
Tue, 12/7/21 - 11:10 am
GSK
Vir Biotechnology
COVID-19
antibodies
Omicron COVID-19 variant
Infants, kids now have a Covid-19 therapy as FDA expands use of Eli Lilly drug
MedCity News
Sun, 12/5/21 - 10:39 pm
Eli Lilly
FDA
COVID-19
pediatric
antibodies
Regeneron warns its antibody drug may be less potent versus omicron
BioPharma Dive
Tue, 11/30/21 - 10:38 am
Regeneron
antibodies
COVID-19
Omicron COVID-19 variant
The antibody discovery team at Twist bets on mouse model player in a boost to its portfolio
Endpoints
Mon, 11/22/21 - 10:29 am
Twist Bioscience
antibodies
R&D
Why Regeneron's Results for Its COVID Antibody Therapy Won't Boost Sales Much
Motley Fool
Sat, 11/20/21 - 12:01 pm
Regeneron
Roche
COVID-19
antibodies
Passive vaccination? AstraZeneca spotlights six-month protection with Covid-19 antibody among vulnerable group
Endpoints
Thu, 11/18/21 - 10:44 am
AstraZeneca
COVID-19
antibodies
passive vaccination
Acelyrin raises $250M, licenses antibody drug that could rival Novartis, Lilly meds
MedCity News
Tue, 11/16/21 - 10:31 am
Acelyrin
Affibody
antibodies
monoclonal antibodies
immunology
Novartis
Eli Lilly
Twist spins out COVID-19 antibody program, forming startup to advance variant-busting candidate
Fierce Biotech
Tue, 11/16/21 - 10:29 am
Twist Bioscience
COVID-19
antibodies
Revelar Biotherapeutics
GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win
Fierce Pharma
Sat, 11/13/21 - 09:47 pm
GSK
Vir Biotechnology
antibodies
COVID-19
drug delivery
AstraZeneca Will Unite Vaccines, Antibody Therapies in New Division
BioSpace
Tue, 11/9/21 - 11:39 pm
AstraZeneca
vaccines
antibodies
Regeneron COVID-19 antibody drug reduces infection risk 82% in clinical trial
Beckers Hospital Review
Mon, 11/8/21 - 11:03 am
Regeneron
COVID-19
antibodies
clinical trials
Lilly pulls COVID-19 treatment from EU review while U.S. stocks up
Reuters
Wed, 11/3/21 - 11:46 pm
Eli Lilly
antibodies
COVID-19
Europe
Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?
Motley Fool
Fri, 10/22/21 - 12:18 pm
Merck
COVID-19
molnupiravir
Regeneron
Eli Lilly
antibodies
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »